FDA issues new guidance on wet AMD drug development
FDA has new draft guidance for drugmakers pursuing wet AMD, an eye degeneration disease that causes a loss of vision.
While drugmakers aren’t required to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
